Overview
Acute dystonia is a type of extrapyramidal symptom (EPS) that can occur as an adverse effect of antipsychotic medications. It is characterized by involuntary muscle contractions, often affecting the head, neck, and face.
Diagnosis
Diagnosis is primarily clinical, based on the characteristic involuntary muscle contractions occurring shortly after initiation or dose increase of an antipsychotic medication.
No specific diagnostic tests are recommended.
Severity can be graded based on the extent and impact of muscle spasms.Management
Immediate Management:
* Discontinuation or dose reduction of the offending antipsychotic medication.
* Administration of anticholinergic medications, such as benztropine or diphenhydramine, is the mainstay of acute treatment.
Adjunctive Treatment:
* Benzodiazepines may be used for severe or refractory cases.
* Switching to an antipsychotic with a lower propensity for EPS, such as clozapine or quetiapine, may be considered for long-term management.Special Populations
No specific information regarding special populations (pregnancy, pediatrics, elderly, comorbidities) was found in the provided abstracts.Key Recommendations
Acute dystonia is managed by discontinuing or reducing the dose of the causative antipsychotic medication and administering anticholinergic agents 1. (Evidence: Moderate)
Anticholinergic medications like benztropine or diphenhydramine are considered first-line treatment for acute dystonia. (Evidence: Moderate)
Switching to an antipsychotic with a lower risk of extrapyramidal symptoms may be a strategy for long-term management. (Evidence: Moderate)References
1 Schneider-Thoma J, Zhu Y, Qin M, Dong Y, Guan S, Wang J et al.. Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databases. Lancet (London, England) 2026. link02365-7)
2 Brandt L, Schneider-Thoma J, Siafis S, Efthimiou O, Bermpohl F, Loncar L et al.. Adverse events after antipsychotic discontinuation: an individual participant data meta-analysis. The lancet. Psychiatry 2022. link00014-1)